Alvotech (ALVO) Research & Development (2021 - 2026)
Alvotech (ALVO) posted Research & Development of -$24.5 million for Q1 2026, down 107.46% on a QoQ basis from $328.7 million in Q4 2025, and up 35.78% year-over-year from -$18.1 million in Q1 2025.
Alvotech (ALVO) Research & Development (2021 - 2026) Analysis & Trends
Alvotech's Research & Development history runs 6 years deep, the most recent figure standing at -$24.5 million for Q1 2026.
- Quarterly Research & Development rose 35.78% year-over-year to -$24.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $197.9 million (up 158.11% YoY) and the FY2025 annual result came in at $184.2 million, up 7.52% from the prior year.
- Research & Development was -$24.5 million for Q1 2026 at Alvotech, down from $328.7 million in the prior quarter.
- Across five years, Research & Development topped out at $328.7 million in Q4 2025 and bottomed at -$210.8 million in Q4 2023.
- A 5-year average of -$53.4 million and a median of -$51.6 million in 2025 frame the typical range for Research & Development.
- Peak annual rise in Research & Development reached 291.87% in 2025, while the deepest fall reached 76442.07% in 2025.
- Alvotech's Research & Development stood at -$180.6 million in 2022, then retreated by 16.72% to -$210.8 million in 2023, then gained by 18.74% to -$171.3 million in 2024, then soared by 291.87% to $328.7 million in 2025, then sank by 107.46% to -$24.5 million in 2026.
- Business Quant data shows ALVO's Research & Development at -$24.5 million in Q1 2026, $328.7 million in Q4 2025, and -$51.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 696.00 Mn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 180.00 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 7.37 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 138.20 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 248.60 Mn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 296.20 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 97.00 Mn |
| 10 | Alvotech | 899.08 Mn | 899.08 Mn | 5.09 Mn | -24.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -24.51 Mn |
| Dec 31, 2025 | 328.70 Mn |
| Sep 30, 2025 | -51.62 Mn |
| Jun 30, 2025 | -54.72 Mn |
| Mar 31, 2025 | -38.17 Mn |
| Dec 31, 2024 | -171.31 Mn |
| Sep 30, 2024 | -33.57 Mn |
| Jun 30, 2024 | -97.43 Mn |
| Mar 31, 2024 | -49,868.00 |
| Dec 31, 2023 | -210.83 Mn |
| Aug 31, 2023 | -99.58 Mn |
| Jun 30, 2023 | -99.53 Mn |
| Mar 31, 2023 | -50,864.00 |
| Dec 31, 2022 | -180.62 Mn |
| Aug 31, 2022 | -86.88 Mn |
| Jun 30, 2022 | -39.75 Mn |
| Mar 31, 2022 | -47.14 Mn |
| Dec 31, 2021 | 337.61 Mn |
| Sep 30, 2021 | -56.20 Mn |